Search Results - Schiffmann, Raphael

Screening, diagnosis, and management of patients with Fabry disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference by Schiffmann, Raphael (Author) , Ries, Markus (Author) ,

• Verlag, Volltext
• Verlag, Volltext

Fabry disease: a disorder of childhood onset by Schiffmann, Raphael (Author) , Ries, Markus (Author) ,

• Verlag, Volltext
• Verlag, Volltext

A prospective 10-year study of individualized, intensified enzyme replacement therapy in advanced Fabry disease by Schiffmann, Raphael (Author) , Ries, Markus (Author) ,

• Verlag, Volltext

Parapelvic kidney cysts: a distinguishing feature with high prevalence in Fabry disease by Ries, Markus (Author) , Bove Bettis, Karen E. (Author) , Choyke, Peter (Author) , Kopp, Jeffrey B. (Author) , Austin, Howard A. (Author) , Brady, Roscoe Owen (Author) , Schiffmann, Raphael (Author) ,

• Verlag, Volltext
• Verlag, Volltext

Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfa by Schiffmann, Raphael (Author) , Ries, Markus (Author) , Blankenship, Derek (Author) , Nicholls, Kathy (Author) , Mehta, Atul (Author) , Clarke, Joe T. R. (Author) , Steiner, Robert D. (Author) , Beck, Michael (Author) , Barshop, Bruce A. (Author) , Rhead, William (Author) , West, Michael (Author) , Martin, Rick (Author) , Amato, David (Author) , Nair, Nitin (Author) , Huertas, Pedro (Author) ,

• Verlag, lizenzpflichtig, Volltext
• Verlag, lizenzpflichtig, Volltext

Four-year prospective clinical trial of agalsidase alfa in children with Fabry disease by Schiffmann, Raphael (Author) , Ries, Markus (Author) ,

• Verlag, Volltext
• Verlag, Volltext

Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry data by Mehta, Atul B. (Author) , Beck, Michael (Author) , Elliott, P. (Author) , Giugliani, R. (Author) , Linhart, A. (Author) , Sunder-Plassmann, Gere (Author) , Schiffmann, Raphael (Author) , Barbey, F. (Author) ,

Randomized, controlled trial of miglustat in Gaucher’s disease type 3 by Schiffmann, Raphael (Author) , Ries, Markus (Author) ,

• Verlag, Volltext
• Verlag, Volltext

Weekly enzyme replacement therapy may slow decline of renal function in patients with Fabry disease who are on long-term biweekly dosing by Schiffmann, Raphael (Author) , Ries, Markus (Author) ,

• Verlag, Volltext
• Verlag, Volltext

Proteomics of specific treatment-related alterations in Fabry disease: a strategy to identify biological abnormalities by Moore, David F. (Author) , Krokhin, Oleg V. (Author) , Beavis, Ronald C. (Author) , Ries, Markus (Author) , Robinson, Chevalia (Author) , Goldin, Ehud (Author) , Brady, Roscoe O. (Author) , Wilkins, John A. (Author) , Schiffmann, Raphael (Author) ,

• Verlag, Volltext
• Verlag, Volltext

Enzyme replacement therapy in orphan and ultra-orphan diseases by Moore, David F. (Author) , Ries, Markus (Author) , Forget, Evelyn L. (Author) , Schiffmann, Raphael (Author) ,

• Verlag, Volltext

Myeloperoxidase predicts risk of vasculopathic events in hemizgygous males with Fabry disease by Kaneski, Christine R. (Author) , Moore, David F. (Author) , Ries, Markus (Author) , Zirzow, G. C. (Author) , Schiffmann, Raphael (Author) ,

• Verlag, Volltext
• Verlag, Volltext

Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease by Ries, Markus (Author) , Clarke, Joe T. R. (Author) , Whybra-Trümpler, Catharina (Author) , Timmons, Margaret (Author) , Robinson, Chevalia (Author) , Schlaggar, Bradley L. (Author) , Pastores, Gregory (Author) , Lien, Y. Howard (Author) , Kampmann, Christoph (Author) , Brady, Roscoe Owen (Author) , Beck, Michael (Author) , Schiffmann, Raphael (Author) ,

• Verlag, Volltext
• Verlag, Volltext

Enzyme replacement therapy and intraepidermal innervation density in Fabry disease by Schiffmann, Raphael (Author) , Hauer, Peter (Author) , Freeman, Barbara (Author) , Ries, Markus (Author) , Scott, Leland J. C. (Author) , Polydefkis, Michael (Author) , Brady, Roscoe O. (Author) , McArthur, Justin C. (Author) , Wagner, Kathryn (Author) ,

• Verlag, Volltext
• Verlag, Volltext

Pathological findings in a patient with Fabry disease who died after 2.5 years of enzyme replacement by Schiffmann, Raphael (Author) , Rapkiewicz, Amy (Author) , Abu-Asab, Mones (Author) , Ries, Markus (Author) , Askari, Hasan (Author) , Tsokos, Maria (Author) , Quezado, Martha (Author) ,

• Verlag, Volltext

Quantitative dysmorphology assessment in Fabry disease by Ries, Markus (Author) , Moore, David F. (Author) , Robinson, Chevalia J. (Author) , Tifft, Cynthia J. (Author) , Rosenbaum, Kenneth N. (Author) , Brady, Roscoe Owen (Author) , Schiffmann, Raphael (Author) , Krasnewich, Donna (Author) ,

• Verlag, Volltext
• Verlag, Volltext

Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting by Schiffmann, Raphael (Author) , Ries, Markus (Author) , Timmons, Margaret (Author) , Flaherty, John T. (Author) , Brady, Roscoe Owen (Author) ,

• Verlag, Volltext
• Verlag, Volltext

Fabry's disease: an important risk factor for stroke by Schiffmann, Raphael (Author) , Ries, Markus (Author) ,

• Verlag, Volltext
• Verlag, Volltext

The relationship of vascular glycolipid storage to clinical manifestations of Fabry disease by Gupta, Surya N. (Author) , Ries, Markus (Author) , Kotsopoulos, Steven (Author) , Schiffmann, Raphael (Author) ,

• Verlag, Volltext

Fabry Disease: angiokeratoma, biomarker, and the effect of enzyme replacement therapy on kidney function by Ries, Markus (Author) , Schiffmann, Raphael (Author) ,

• Verlag, Volltext
• Verlag, Volltext